·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ ±èÀ§ÇÐ, ºÐȸÀåÇùÀÇȸ¼ ¼¿ï½Ã¾àȸÀå ¼±°ÅÃ⸶ ¼±¾ð ±â»çÀÔ·Â : 24.09.26 10:01:48 0 °¡ ÇÃÄ£Ãß°¡ 25ÀÏ Àú³á Á¤·Ê¸ðÀÓ¼ ÀÔÀå ¹àÇô...Ã⸶ȸ°ß ¾ÕµÎ°í äºñ [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ±èÀ§ÇÐ ¼¿ï ºÐȸÀåÇùÀÇȸÀå(Á߶û±¸¾à»çȸÀå)ÀÌ ¾îÁ¦(25ÀÏ) ¹ã 24°³ ±¸¾à»çȸÀå Á¤·Ê ¸ðÀÓ¿¡¼ ¼¿ï½Ã¾à»çȸÀå ¼±°Å Ã⸶ Àǻ縦 ¹àÇû´Ù. ½Ã¾à»çȸÀå È帷ΠÇϸ¶Æò¿¡ ¿Ã¶ú´ø ±èÀ§ÇРȸÀåÀº ±×µ¿¾È¿¡µµ Á÷°£Á¢ÀûÀ¸·Î Ã⸶ Àǻ縦 ³»ºñÄ£ ¹Ù ÀÖ´Ù. À̳¯ Á¤·Ê ¸ðÀÓ¿¡¼´Â ÇѾà»ç ¹®Á¦¿Í ¾à»çȸ Çö¾È, 29ÀÏ ¿¸®´Â °Ç°¼¿ïÆ佺Ƽ¹úÀÇ ¼º°øÀû °³ÃÖ¸¦ ³íÀÇÇß´Ù. ȸÀǸ¦ ¸¶Ä¡¸ç ±è ȸÀåÀº ÁöºÎÀå ¼±°Å¿¡ µµÀüÇÏ°Ú´Ù´Â ¶æÀ» Àü´ÞÇÏ°í ºÐȸÀåµéÀÇ °Ý·Á¸¦ ¹Þ¾Ò´Ù. °ø½ÄÀûÀÎ Ã⸶ ±âÀÚȸ°ßÀº 30ÀÏ ¿ÀÈÄ¿¡ ÀÖÀ» ¿¹Á¤ÀÌ´Ù. Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [Çѵ¶] MI ¸Å´ÏÀú/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¼¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â Medical Information Associate ¹Ù·Î°¡±â ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ±èÀ§ÇÐ, ºÐȸÀåÇùÀÇȸ¼ ¼¿ï½Ã¾àȸÀå ¼±°ÅÃ⸶ ¼±¾ð URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ±èÀ§ÇÐ, ºÐȸÀåÇùÀÇȸ¼ ¼¿ï½Ã¾àȸÀå ¼±°ÅÃ⸶ ¼±¾ð ±â»çÀÔ·Â : 24.09.26 10:01:48 0 °¡ ÇÃÄ£Ãß°¡ 25ÀÏ Àú³á Á¤·Ê¸ðÀÓ¼ ÀÔÀå ¹àÇô...Ã⸶ȸ°ß ¾ÕµÎ°í äºñ [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ±èÀ§ÇÐ ¼¿ï ºÐȸÀåÇùÀÇȸÀå(Á߶û±¸¾à»çȸÀå)ÀÌ ¾îÁ¦(25ÀÏ) ¹ã 24°³ ±¸¾à»çȸÀå Á¤·Ê ¸ðÀÓ¿¡¼ ¼¿ï½Ã¾à»çȸÀå ¼±°Å Ã⸶ Àǻ縦 ¹àÇû´Ù. ½Ã¾à»çȸÀå È帷ΠÇϸ¶Æò¿¡ ¿Ã¶ú´ø ±èÀ§ÇРȸÀåÀº ±×µ¿¾È¿¡µµ Á÷°£Á¢ÀûÀ¸·Î Ã⸶ Àǻ縦 ³»ºñÄ£ ¹Ù ÀÖ´Ù. À̳¯ Á¤·Ê ¸ðÀÓ¿¡¼´Â ÇѾà»ç ¹®Á¦¿Í ¾à»çȸ Çö¾È, 29ÀÏ ¿¸®´Â °Ç°¼¿ïÆ佺Ƽ¹úÀÇ ¼º°øÀû °³ÃÖ¸¦ ³íÀÇÇß´Ù. ȸÀǸ¦ ¸¶Ä¡¸ç ±è ȸÀåÀº ÁöºÎÀå ¼±°Å¿¡ µµÀüÇÏ°Ú´Ù´Â ¶æÀ» Àü´ÞÇÏ°í ºÐȸÀåµéÀÇ °Ý·Á¸¦ ¹Þ¾Ò´Ù. °ø½ÄÀûÀÎ Ã⸶ ±âÀÚȸ°ßÀº 30ÀÏ ¿ÀÈÄ¿¡ ÀÖÀ» ¿¹Á¤ÀÌ´Ù. Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â [Çѵ¶] MI ¸Å´ÏÀú/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¼¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â Medical Information Associate ¹Ù·Î°¡±â ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ±èÀ§ÇÐ, ºÐȸÀåÇùÀÇȸ¼ ¼¿ï½Ã¾àȸÀå ¼±°ÅÃ⸶ ¼±¾ð URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ ±èÀ§ÇÐ, ºÐȸÀåÇùÀÇȸ¼ ¼¿ï½Ã¾àȸÀå ¼±°ÅÃ⸶ ¼±¾ð ±â»çÀÔ·Â : 24.09.26 10:01:48 0 °¡ ÇÃÄ£Ãß°¡ 25ÀÏ Àú³á Á¤·Ê¸ðÀÓ¼ ÀÔÀå ¹àÇô...Ã⸶ȸ°ß ¾ÕµÎ°í äºñ [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ±èÀ§ÇÐ ¼¿ï ºÐȸÀåÇùÀÇȸÀå(Á߶û±¸¾à»çȸÀå)ÀÌ ¾îÁ¦(25ÀÏ) ¹ã 24°³ ±¸¾à»çȸÀå Á¤·Ê ¸ðÀÓ¿¡¼ ¼¿ï½Ã¾à»çȸÀå ¼±°Å Ã⸶ Àǻ縦 ¹àÇû´Ù. ½Ã¾à»çȸÀå È帷ΠÇϸ¶Æò¿¡ ¿Ã¶ú´ø ±èÀ§ÇРȸÀåÀº ±×µ¿¾È¿¡µµ Á÷°£Á¢ÀûÀ¸·Î Ã⸶ Àǻ縦 ³»ºñÄ£ ¹Ù ÀÖ´Ù. À̳¯ Á¤·Ê ¸ðÀÓ¿¡¼´Â ÇѾà»ç ¹®Á¦¿Í ¾à»çȸ Çö¾È, 29ÀÏ ¿¸®´Â °Ç°¼¿ïÆ佺Ƽ¹úÀÇ ¼º°øÀû °³ÃÖ¸¦ ³íÀÇÇß´Ù. ȸÀǸ¦ ¸¶Ä¡¸ç ±è ȸÀåÀº ÁöºÎÀå ¼±°Å¿¡ µµÀüÇÏ°Ú´Ù´Â ¶æÀ» Àü´ÞÇÏ°í ºÐȸÀåµéÀÇ °Ý·Á¸¦ ¹Þ¾Ò´Ù. °ø½ÄÀûÀÎ Ã⸶ ±âÀÚȸ°ßÀº 30ÀÏ ¿ÀÈÄ¿¡ ÀÖÀ» ¿¹Á¤ÀÌ´Ù. Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : ±èÀ§ÇÐ, ºÐȸÀåÇùÀÇȸ¼ ¼¿ï½Ã¾àȸÀå ¼±°ÅÃ⸶ ¼±¾ð URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö